Pages that link to "Q74576864"

The following pages link to Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia (Q74576864):

Displaying 41 items.

• ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity (Q24299738) (← links)
• Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase (Q26784116) (← links)
• Infertility with defective spermiogenesis in mice lacking AF5q31, the target of chromosomal translocation in human infant leukemia (Q28513902) (← links)
• Fludarabine, idarubicin, and cytarabine regimen together with TKI followed by haploidentical hematopoietic stem cell transplantation, a success for relapsed Ph+ acute lymphoblastic leukemia (Q30276948) (← links)
• Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia (Q33591867) (← links)
• Establishment of a novel human lymphoblastic cell strain with the long arm of chromosome 11 aberration without MLL rearrangement (Q33678485) (← links)
• Fluorescent-magnetic-biotargeting multifunctional nanobioprobes for detecting and isolating multiple types of tumor cells (Q33798318) (← links)
• Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemia (Q33840913) (← links)
• Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes (Q33915980) (← links)
• Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11) (Q34005240) (← links)
• Comparison of hematopoietic stem cells derived from fresh and cryopreserved whole cord blood in the generation of humanized mice. (Q34447462) (← links)
• Resveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD/SCID mouse model (Q35722481) (← links)
• Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice (Q36642975) (← links)
• Oral or parenteral administration of curcumin does not prevent the growth of high-risk t(4;11) acute lymphoblastic leukemia cells engrafted into a NOD/SCID mouse model (Q36643470) (← links)
• Aptamer-Functionalized Fluorescent Silica Nanoparticles for Highly Sensitive Detection of Leukemia Cells (Q37004545) (← links)
• Impact of aberrant DNA methylation patterns including CYP1B1 methylation in adolescents and young adults with acute lymphocytic leukemia (Q37627410) (← links)
• Adult acute lymphoblastic leukemia: concepts and strategies (Q37681450) (← links)
• Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults (Q37695157) (← links)
• Treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia with imatinib in combination with chemotherapy (Q37738455) (← links)
• New approaches to the management of Philadelphia-chromosome-positive acute lymphocytic leukemia (Q37738486) (← links)
• Managing Philadelphia chromosome-positive acute lymphoblastic leukemia: role of tyrosine kinase inhibitors (Q37875969) (← links)
• Targeting Epigenetics through Histone Deacetylase Inhibitors in Acute Lymphoblastic Leukemia (Q37901485) (← links)
• CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL (Q38283414) (← links)
• Profiling gene mutations, translocations, and multidrug resistance in pediatric acute lymphoblastic leukemia: a step forward to personalizing medicine (Q38756273) (← links)
• Withaferin A activates stress signalling proteins in high risk acute lymphoblastic leukemia (Q38793590) (← links)
• Magnetic Nanoparticles PCR Enzyme-Linked Gene Assay for Quantitative Detection of BCR/ABL Fusion Gene in Chronic Myelogenous Leukemia. (Q38811738) (← links)
• Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia (Q39010282) (← links)
• Functional genomics of tumor suppressor miR-196b in T-cell acute lymphoblastic leukemia (Q39647847) (← links)
• The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells (Q39695490) (← links)
• Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B‐lymphoblastic leukemia in the era of tyrosine kinase inhibitors (Q41299717) (← links)
• The pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cells. (Q41840259) (← links)
• Isochromosome 9q as a sole anomaly in an Omani boy with acute lymphoblastic leukaemia (Q42099867) (← links)
• Differential effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway in acute lymphoblastic leukemia. (Q42906858) (← links)
• JS-K; a nitric oxide-releasing prodrug, modulates β-catenin/TCF signaling in leukemic Jurkat cells: Evidence of an S-nitrosylated mechanism (Q42924914) (← links)
• Relationship between chromosomal changes complexity and disease aggressiveness in myeloid and lymphoid disorders. (Q44205240) (← links)
• Chromosome abnormalities in T-cell acute lymphoblastic leukemia in Korea. (Q53298144) (← links)
• RT-PCR and real-time PCR analysis of E2A-PBX1, TEL-AML1, mBCR-ABL and MLL-AF4 fusion gene transcripts in de novo B-lineage acute lymphoblastic leukaemia patients in south India (Q54352142) (← links)
• Phenotyping and Target Expression Profiling of CD34+/CD38- and CD34+/CD38+ Stem- and Progenitor cells in Acute Lymphoblastic Leukemia. (Q55263277) (← links)
• Targeting STAT5 or STAT5-Regulated Pathways Suppresses Leukemogenesis of Ph+ Acute Lymphoblastic Leukemia (Q57461994) (← links)
• Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and independent effects by CDK6-specific PROTACs (Q89629372) (← links)
• A systematic literature review and meta-analysis of minimal residual disease as a prognostic indicator in adult B-cell acute lymphoblastic leukemia (Q92487658) (← links)